Anticancer Therapies – Products

Company to participate in the World Money Show in Orlando, Fl., Booth #609, held on February 9 -12.

The Simcyp Mouse provides a virtual environment for evaluating drug disposition which will replace the need for some live animal testing in normal as well as transgenic mice, thus reducing and refining preclinical investigation.

New research published in BioMed Central’s open access journal Child and Adolescent Psychiatry and Mental Health shows that a teaching program, designed to improve the child’s knowledge about their sibling’s disease and to give them coping skills, was able to improve their adjustment and psychological well being in this early time period after diagnosis.

The company announced it has launched a personalized medicine service that empowers cancer patients and their oncology teams to develop treatment strategies based on insight into the biology of individual tumors.

New test enables rapid, appropriate selection of CRC patients for anti-EGFR therapy.

High morbidity rates make early diagnosis and therapy assignment crucial. The Randox test enables rapid, appropriate selection of colorectal cancer (CRC) patients for anti-EGFR therapy, therefore maximising drug efficacy and minimising adverse side effects to the patient.

High immune response rate of 84% in heavily pre-treated NSCLC patients.

Zetasizer Nano from Malvern Instruments measure particle size, zeta potential and molecular weight.

New DeltaVision OMX Blaze will accelerate scientists’ understanding of disease mechanisms at the molecular level.